Emcure Pharmaceuticals Limited — JV/Acquisition, 21-06-2025: Acquisition

Emcure has announced a board meeting on the approved acquisition of the remaining 20.42% stake in its subsidiary Zuventus Healthcare, making it a wholly-owned unit. The deal values the shares at Rs. 724.9 Cr, payable in cash. Zuventus, incorporated in 2002, operates in pharmaceuticals with a steady revenue ramp, posting Rs. 1,079.9 Cr turnover and Rs. 134.78 Cr PAT in FY25. Full ownership strengthens Emcure’s control over Zuventus’s pharma portfolio, enhancing operational synergy and strategic alignment within its core healthcare business. Completion is targeted by September 2025.